Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C53 - Status Epilepticus Update

Sunday 04/14/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | Bluebird 1A
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Clio A. Rubinos, MD
Epilepsy/Clinical Neurophysiology (EEG)
Participants should comprehend the pathophysiological rationale for administering essential early-stage medications to prevent the progression of status epilepticus; recognize and address various types and phases of status epilepticus, including NORSE; and develop an approach to managing challenging EEG patterns such as periodic discharges and the ictal-interictal continuum.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials

Event Timeline
01:00 PM - 01:05 PM MDT Introduction Introduction
Clio A. Rubinos, MD
01:05 PM - 01:30 PM MDT Speaker Status Epilepticus: The Golden Hour Treatment
LUIS OTAVIO CABOCLO, MD,PhD
01:30 PM - 01:55 PM MDT Speaker Refractory and Super Refractory Status Epilepticus: What Can We Do?
Clio A. Rubinos, MD
01:55 PM - 02:20 PM MDT Speaker Periodic and Rhythmic Patterns: When to Treat and How?
Suzette M. LaRoche, MD, FAAN
02:20 PM - 02:30 PM MDT Q&A Questions and Answers
Suzette M. LaRoche, MD, FAAN
02:30 PM - 02:40 PM MDT Speaker Patient Experience Sharing Video
Clio A. Rubinos, MD
02:40 PM - 03:00 PM MDT Discussion Interactive Game—Status Patronus: How Would You Treat This Status Epilepticus Patient? With Panel Commentary
Clio A. Rubinos, MD, Suzette M. LaRoche, MD, FAAN
Faculty Disclosures
Clio A. Rubinos, MD Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Epilepsy Society . Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
Suzette M. LaRoche, MD, FAAN Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to AAN interests or activities.
LUIS OTAVIO CABOCLO, MD,PhD Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Libbs Phamaceutical. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adium Pharmaceutical. Dr. CABOCLO has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Endogen Pharmaceutical (Brazil). Dr. CABOCLO has stock in Endogen Pharmaceutical (Brazil).